Danish bank expects slow start to 2022 for Coloplast, lowers price target

Especially Coloplast's continence division is challenged, assesses Danish bank Jyske Bank, which is subsequently lowering its share price target for the medtech company ahead of its Q1 financial report.
Photo: Coloplast / PR
Photo: Coloplast / PR
by marketwire, translated by daniel pedersen

Danish bank Jyske bank is lowering its share price target for medtech company Coloplast prior to the release of its first quarter results on Jan. 25.

Already a subscriber?Log in here

Read the whole article

Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

With your free trial you get:

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
Must be at least 8 characters, including three of: Uppercase, lowercase, numbers, symbols
Must contain at least 2 characters
Must contain at least 2 characters

Get full access for you and your coworkers

Start a free company trial today

Share article

Sign up for our newsletter

Stay ahead of development by receiving our newsletter on the latest sector knowledge.

Newsletter terms

Front page now

Further reading